Publications

Our consultants and scientists have numerous publications but only their key publications from 2006 – 2012 and papers in press have been included on this site. These key publications include ordinary journal articles and reviews only.

2012

ANING, J. and GILLATT, D., 2012. When should patients with varicocoele be referred? The Practitioner, 256(1750), pp. 17-20, 2-3.

BURTON, A.J., MARTIN, R.M., DONOVAN, J.L., ATHENE LANE, J., DAVIS, M., HAMDY, F.C., NEAL, D.E. and TILLING, K., 2012. Associations of lifestyle factors and anthropometric measures with repeat PSA levels during active surveillance/monitoring. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, .

DICKINSON, L., AHMED, H.U., ALLEN, C., BARENTSZ, J.O., CAREY, B., FUTTERER, J.J., HEIJMINK, S.W., HOSKIN, P., KIRKHAM, A.P., PADHANI, A.R., PERSAD, R., PUECH, P., PUNWANI, S., SOHAIB, A., TOMBAL, B., VILLERS, A. and EMBERTON, M., 2012. Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: Could standardization lead to improved utilization of imaging within the diagnostic pathway? Journal of magnetic resonance imaging : JMRI, .

EYLERT, M.F., BAHL, A. and PERSAD, R., 2012. Do we need to obtain consent for penile shortening as a complication of treatment for organ-confined prostate cancer? BJU international, .

GILBERT, R., MARTIN, R.M., FRASER, W.D., LEWIS, S., DONOVAN, J., HAMDY, F., NEAL, D.E., LANE, J.A. and METCALFE, C., 2012. Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the prostate testing for cancer and treatment study. Cancer causes & control : CCC, 23(4), pp. 575-588.

GNANAPRAGASAM, V.J., PERSAD, R. and PAYNE, H.A., 2012. Radiotherapy and surgery for high-risk localized prostate cancer: a uk questionnaire survey of urologists and clinical oncologists. BJU international, 110(5), pp. 608-612.
HAGEN, R.M. and LADOMERY, M.R., 2012. Role of splice variants in the metastatic progression of prostate cancer. Biochemical Society transactions, 40(4), pp. 870-874.

HOLLY, J.M. and PERKS, C.M., 2012. Insulin-like growth factor physiology: what we have learned from human studies. Endocrinology and metabolism clinics of North America, 41(2), pp. 249-63, v.

MASSON, S., PERSAD, R. and BAHL, A., 2012. HDR Brachytherapy in the Management of High-Risk Prostate Cancer. Advances in urology, 2012, pp. 980841.

NG, C.H., PATHY, N.B., TAIB, N.A., MUN, K.S., RHODES, A. and YIP, C.H., 2012. The Estrogen Receptor Negative-Progesterone Receptor Positive Breast Carcinoma is a Biological Entity and not a Technical Artifact. Asian Pacific journal of cancer prevention : APJCP, 13(4), pp. 1111-1113.

OLTEAN, S., GAMMONS, M., HULSE, R., HAMDOLLAH-ZADEH, M., MAVROU, A., DONALDSON, L., SALMON, A.H., HARPER, S.J., LADOMERY, M.R. and BATES, D.O., 2012. SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases. Biochemical Society transactions, 40(4), pp. 831-835.

PERKS, C.M. and HOLLY, J.M., 2012. Insulin-like growth factors in health and disease. Preface. Endocrinology and metabolism clinics of North America, 41(2), pp. xv-xvi.

RANASINGHE, W.K., DE SILVA, D., DE SILVA, M.V., RANASINGHE, T.I., LAWRENTSCHUK, N., BOLTON, D. and PERSAD, R., 2012. Incidence of bladder cancer in sri lanka: analysis of the cancer registry data and review of the incidence of bladder cancer in the South asian population. Korean journal of urology, 53(5), pp. 304-309.

ROWLANDS, M.A., HOLLY, J.M., GUNNELL, D., DONOVAN, J., LANE, J.A., HAMDY, F., NEAL, D.E., OLIVER, S., SMITH, G.D. and MARTIN, R.M., 2012. Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT. Cancer research, 72(2), pp. 503-515.

ROWLANDS, M.A., HOLLY, J.M., HAMDY, F., PHILLIPS, J., GOODWIN, L., MARSDEN, G., GUNNELL, D., DONOVAN, J., NEAL, D.E. and MARTIN, R.M., 2012. Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer. Cancer causes & control : CCC, 23(2), pp. 347-354.

THANKAMONY, A., ONG, K.K., AHMED, M.L., NESS, A.R., HOLLY, J.M. and DUNGER, D.B., 2012. Higher levels of IGF-I and adrenal androgens at age 8 years are associated with earlier age at menarche in girls. The Journal of clinical endocrinology and metabolism, 97(5), pp. E786-90.

WINSTOCK, A.R., MITCHESON, L., GILLATT, D.A. and COTTRELL, A.M., 2012. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU international, .

2011

AMIN, E.M., OLTEAN, S., HUA, J., GAMMONS, M.V., HAMDOLLAH-ZADEH, M., WELSH, G.I., CHEUNG, M.K., NI, L., KASE, S., RENNEL, E.S., SYMONDS, K.E., NOWAK, D.G., ROYER-POKORA, B., SALEEM, M.A., HAGIWARA, M., SCHUMACHER, V.A., HARPER, S.J., HINTON, D.R., BATES, D.O. and LADOMERY, M.R., 2011. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer cell, 20(6), pp. 768-780.

BRAUSI, M., WITJES, J.A., LAMM, D., PERSAD, R., PALOU, J., COLOMBEL, M., BUCKLEY, R., SOLOWAY, M., AKAZA, H. and BOHLE, A., 2011. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. The Journal of urology, 186(6), pp. 2158-2167.

CHAMBERLAIN, C., ROMUNDSTAD, P., VATTEN, L., GUNNELL, D. and MARTIN, R.M., 2011. The association of weight gain during adulthood with prostate cancer incidence and survival: a population-based cohort. International journal of cancer.Journal international du cancer, 129(5), pp. 1199-1206.

CHANDRASHEKHARA, S.H., MANJUNATHA, Y.C., MUZUMDER, S., BAHL, A., DAS, P., SURI, V. and THULKAR, S., 2011. Multicentric sinus histicytosis (Rosai-Dorfman Disease): Computed tomography, magnetic resonance imaging findings. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology, 32(3), pp. 174-176.

COLLIN, S.M., METCALFE, C., PALMER, T.M., REFSUM, H., LEWIS, S.J., SMITH, G.D., COX, A., DAVIS, M., MARSDEN, G., JOHNSTON, C., LANE, J.A., DONOVAN, J.L., NEAL, D.E., HAMDY, F.C., SMITH, A.D. and MARTIN, R.M., 2011. The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers? International journal of molecular epidemiology and genetics, 2(4), pp. 316-327.

DICKINSON, L., AHMED, H.U., ALLEN, C., BARENTSZ, J.O., CAREY, B., FUTTERER, J.J., HEIJMINK, S.W., HOSKIN, P.J., KIRKHAM, A., PADHANI, A.R., PERSAD, R., PUECH, P., PUNWANI, S., SOHAIB, A.S., TOMBAL, B., VILLERS, A., VAN DER MEULEN, J. and EMBERTON, M., 2011. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. European urology, 59(4), pp. 477-494.

DOWN, L., METCALFE, C., MARTIN, R.M., NEAL, D.E., HAMDY, F.C., DONOVAN, J.L. and LANE, J.A., 2011. Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK. BJU international, 108(9), pp. 1409-1414.

GILBERT, R., MARTIN, R.M., BEYNON, R., HARRIS, R., SAVOVIC, J., ZUCCOLO, L., BEKKERING, G.E., FRASER, W.D., STERNE, J.A. and METCALFE, C., 2011. Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. Cancer causes & control : CCC, 22(3), pp. 319-340.

JEFFERIES, E.R., THURAIRAJA, R., PERSAD, R.A., RAJANI, R., PHULL, J.S. and BAHL, A., 2011. Don't think once, think twice! the cardiovascular effects of androgen deprivation therapy. BJU international, 107(7), pp. 1023-1028.
LIU, Y.T. and BAHL, A., 2011. Evaluation of proper above-the-diaphragm central venous catheter placement: the saline flush test. The American Journal of Emergency Medicine, 29(7), pp. 842.e1-842.e3.

PASHAYAN, N., PHAROAH, P., TABAR, L., NEAL, D.E., MARTIN, R.M., DONOVAN, J., HAMDY, F. and DUFFY, S.W., 2011. Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence. Cancer epidemiology, 35(2), pp. 139-144.

RANASINGHE, W.K., SIBANDA, T., DE SILVA, M.V., RANASINGHE, T.I. and PERSAD, R., 2011. Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England. BJU international, 108(8 Pt 2), pp. E184-9.

RICKETTS, S.L., RENSING, K.L., HOLLY, J.M., CHEN, L., YOUNG, E.H., LUBEN, R., ASHFORD, S., SONG, K., YUAN, X., DEHGHAN, A., WRIGHT, B.J., WATERWORTH, D.M., MOOSER, V., GEMS INVESTIGATORS, WAEBER, G., VOLLENWEIDER, P., EPSTEIN, S.E., BURNETT, M.S., DEVANEY, J.M., HAKONARSON, H.H., RADER, D.J., REILLY, M.P., DANESH, J., THOMPSON, S.G., DUNNING, A.M., VAN DUIJN, C.M., SAMANI, N.J., MCPHERSON, R., WAREHAM, N.J., KHAW, K.T., BOEKHOLDT, S.M. and SANDHU, M.S., 2011. Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease. International journal of molecular epidemiology and genetics, 2(3), pp. 261-285.

THOMAS, F., HOLLY, J.M., PERSAD, R., BAHL, A. and PERKS, C.M., 2011. Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells. Urology, 78(2), pp. 475.e15-475.e21.

UZOH, C.C., HOLLY, J.M., BIERNACKA, K.M., PERSAD, R.A., BAHL, A., GILLATT, D. and PERKS, C.M., 2011. Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel. British journal of cancer, 104(10), pp. 1587-1593.

WILLIAMS, N., HUGHES, L.J., TURNER, E.L., DONOVAN, J.L., HAMDY, F.C., NEAL, D.E., MARTIN, R.M. and METCALFE, C., 2011. Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities. BJU international, 108(9), pp. 1402-1408.

WOOD, D., COTTRELL, A., BAKER, S.C., SOUTHGATE, J., HARRIS, M., FULFORD, S., WOODHOUSE, C. and GILLATT, D., 2011. Recreational ketamine: from pleasure to pain. BJU international, 107(12), pp. 1881-1884.

2010

ASTIN, J.W., BATSON, J., KADIR, S., CHARLET, J., PERSAD, R.A., GILLATT, D., OXLEY, J.D. and NOBES, C.D., 2010. Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nature cell biology, 12(12), pp. 1194-1204.

AYRES, B.E., GRIFFITHS, T.R. and PERSAD, R.A., 2010. Is the role of intravesical bacillus Calmette-Guerin in non-muscle-invasive bladder cancer changing? BJU international, 105 Suppl 2, pp. 8-13.

BAHL, A., DAVIS, P.H., BEHNKE, M., DZIERSZINSKI, F., JAGALUR, M., CHEN, F., SHANMUGAM, D., WHITE, M.W., KULP, D. and ROOS, D.S., 2010. A novel multifunctional oligonucleotide microarray for Toxoplasma gondii. BMC genomics, 11, pp. 603.

BERESFORD, M.J., 2010. Medical reductionism: lessons from the great philosophers. QJM : monthly journal of the Association of Physicians, 103(9), pp. 721-724.

BERESFORD, M.J., GILLATT, D., BENSON, R.J. and AJITHKUMAR, T., 2010. A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence. Clinical oncology (Royal College of Radiologists (Great Britain)), 22(1), pp. 46-55.

BUNCE, C., AYRES, B.E., GRIFFITHS, T.R., MOSTAFID, H., KELLY, J., PERSAD, R. and KOCKELBERGH, R., 2010. The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer. BJU international, 105 Suppl 2, pp. 2-7.

BURTON, A.J., TILLING, K.M., HOLLY, J.M., HAMDY, F.C., ROWLANDS, M.A., DONOVAN, J.L. and MARTIN, R.M., 2010. Metabolic imbalance and prostate cancer progression. International journal of molecular epidemiology and genetics, 1(4), pp. 248-271.

COLLIN, S.M., METCALFE, C., REFSUM, H., LEWIS, S.J., SMITH, G.D., COX, A., DAVIS, M., MARSDEN, G., JOHNSTON, C., LANE, J.A., DONOVAN, J.L., NEAL, D.E., HAMDY, F.C., SMITH, A.D. and MARTIN, R.M., 2010. Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19(11), pp. 2833-2838.

COLLIN, S.M., METCALFE, C., REFSUM, H., LEWIS, S.J., ZUCCOLO, L., SMITH, G.D., CHEN, L., HARRIS, R., DAVIS, M., MARSDEN, G., JOHNSTON, C., LANE, J.A., EBBING, M., BONAA, K.H., NYGARD, O., UELAND, P.M., GRAU, M.V., BARON, J.A., DONOVAN, J.L., NEAL, D.E., HAMDY, F.C., SMITH, A.D. and MARTIN, R.M., 2010. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 19(6), pp. 1632-1642.

EVANS, S., METCALFE, C., PATEL, B., IBRAHIM, F., ANSON, K., CHINEGWUNDOH, F., CORBISHLEY, C., GILLATT, D., KIRBY, R., MUIR, G., NARGUND, V., POPERT, R., WILSON, P., PERSAD, R. and BEN-SHLOMO, Y., 2010. Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort study. British journal of cancer, 102(2), pp. 249-254.

GAO, W., ROMKES, M., ZHONG, S., NUKUI, T., PERSAD, R.A., SMITH, P.J., BRANCH, R. and KEOHAVONG, P., 2010. Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. Oncology reports, 24(1), pp. 257-262.

HOLLY, J.M., 2010. Challenges in endocrinology: moving from the post-genomic era, into the nano-world and beyond. Frontiers in endocrinology, 1, pp. 11.

HOTSTON, M., JEREMY, J.Y., PERSAD, R., BLOOR, J. and SHUKLA, N., 2010. 8-isoprostane F2alpha up-regulates the expression of type 5 phosphodiesterase in cavernosal vascular smooth muscle cells: inhibition with sildenafil, iloprost, nitric oxide and picotamide. BJU international, 106(11), pp. 1794-1798.

KIRCHNER, H., STRUMBERG, D., BAHL, A. and OVERKAMP, F., 2010. Patient-based strategy for systemic treatment of metastatic renal cell carcinoma. Expert review of anticancer therapy, 10(4), pp. 585-596.

LAMM, D., BOHLE, A., PALOU, J., PERSAD, R., BRAUSI, M., COLOMBEL, M., AKAZA, H. and BUCKLEY, R., 2010. Re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56. European urology, 57(2), pp. e7-9; author reply e10-1.

LEWIS, S.J., MURAD, A., CHEN, L., DAVEY SMITH, G., DONOVAN, J., PALMER, T., HAMDY, F., NEAL, D., LANE, J.A., DAVIS, M., COX, A. and MARTIN, R.M., 2010. Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk. PloS one, 5(10), pp. e13485.

MARTIN, R.M., VATTEN, L., GUNNELL, D. and ROMUNDSTAD, P., 2010. Blood pressure and risk of prostate cancer: Cohort Norway (CONOR). Cancer causes & control : CCC, 21(3), pp. 463-472.

MASON, K., COTTRELL, A.M., CORRIGAN, A.G., GILLATT, D.A. and MITCHELMORE, A.E., 2010. Ketamine-associated lower urinary tract destruction: a new radiological challenge. Clinical radiology, 65(10), pp. 795-800.

MCVEY, G.P., MCPHAIL, S., FOWLER, S., MCINTOSH, G., GILLATT, D. and PARKER, C.C., 2010. Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry. BJU international, 106(8), pp. 1161-1164.

MEVCHA, A., GULUR, D.M. and GILLATT, D., 2010. Diagnosing urological disorders in ageing men. The Practitioner, 254(1726), pp. 25-6, 28-9, 2-3.

MOSTAFID, H., PERSAD, R., KOCKELBERGH, R. and FAWCETT, D., 2010. Is it time to re-design the haematuria clinic? BJU international, 105(5), pp. 585-588.

MURAD, A.S., SMITH, G.D., LEWIS, S.J., COX, A., DONOVAN, J.L., NEAL, D.E., HAMDY, F.C. and MARTIN, R.M., 2010. A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study). International journal of molecular epidemiology and genetics, 1(3), pp. 175-183.

PATERNOSTER, L., LORENTZON, M., VANDENPUT, L., KARLSSON, M.K., LJUNGGREN, O., KINDMARK, A., MELLSTROM, D., KEMP, J.P., JARETT, C.E., HOLLY, J.M., SAYERS, A., ST POURCAIN, B., TIMPSON, N.J., DELOUKAS, P., DAVEY SMITH, G., RING, S.M., EVANS, D.M., TOBIAS, J.H. and OHLSSON, C., 2010. Genome-wide association meta-analysis of cortical bone mineral density unravels allelic heterogeneity at the RANKL locus and potential pleiotropic effects on bone. PLoS genetics, 6(11), pp. e1001217.

RATH, G.K., SHARMA, D.N., JULKA, P.K., SUBRAMANI, V., BAHL, A. and HARESH, K.P., 2010. Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience. American journal of clinical oncology, 33(3), pp. 238-241.

ROWLANDS, M.A., HOLLY, J.M., GUNNELL, D., GILBERT, R., DONOVAN, J., LANE, J.A., MARSDEN, G., COLLIN, S.M., HAMDY, F., NEAL, D.E. and MARTIN, R.M., 2010. The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: evidence from the ProtecT (Prostate testing for cancer and Treatment) study. Cancer causes & control : CCC, 21(11), pp. 1829-1842.

SCHMIDT, F., MARNEF, A., CHEUNG, M.K., WILSON, I., HANCOCK, J., STAIGER, D. and LADOMERY, M., 2010. A proteomic analysis of oligo(dT)-bound mRNP containing oxidative stress-induced Arabidopsis thaliana RNA-binding proteins ATGRP7 and ATGRP8. Molecular biology reports, 37(2), pp. 839-845.

SHARMA, D.N., THULKAR, S., GOYAL, S., SHUKLA, N.K., KUMAR, S., RATH, G.K., JULKA, P.K., SAINI, G. and BAHL, A., 2010. Revisiting the role of computerized tomographic scan and cystoscopy for detecting bladder invasion in the revised FIGO staging system for carcinoma of the uterine cervix. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 20(3), pp. 368-372.

SOLSONA, E., BAHL, A., BRANDES, S.B., DICKERSON, D., PURAS-BAEZ, A., VAN POPPEL, H. and WATKIN, N.A., 2010. New developments in the treatment of localized penile cancer. Urology, 76(2 Suppl 1), pp. S36-42.

THOMAS, F., HOLLY, J.M., PERSAD, R., BAHL, A. and PERKS, C.M., 2010. Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor. The Prostate, 70(8), pp. 856-865.

TILLING, K., GARMO, H., METCALFE, C., HOLMBERG, L., HAMDY, F.C., NEAL, D.E., ADOLFSSON, J., MARTIN, R.M., DAVIS, M., FALL, K., LANE, J.A., ADAMI, H.O., BILL-AXELSON, A., JOHANSSON, J.E. and DONOVAN, J.L., 2010. Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts. European urology, 57(3), pp. 446-452.

WHIPP, E., BERESFORD, M., SAWYER, E. and HALLIWELL, M., 2010. True local recurrence rate in the conserved breast after magnetic resonance imaging-targeted radiotherapy. International journal of radiation oncology, biology, physics, 76(4), pp. 984-990.

2009

AYRES, B.E., GILLATT, D.A., MCPHAIL, S., COTTRELL, A., HUGH MOSTAFID, A., FOWLER, S., MCINTOSH, G., VERNE, J., KOCKELBERGH, R. and PERSAD, R.A., 2009. The BAUS urological cancer observatory. BJU international, 104(4), pp. 562.

BAHL, A., KUMAR, M., SHARMA, D.N., JOTHY BASU, K.S., JAURA, M.S., RATH, G.K. and JULKA, P.K., 2009. Reirradiation for progressive brain metastases. Journal of cancer research and therapeutics, 5(3), pp. 161-164.

BASU, K.S., BAHL, A., SUBRAMANI, V., SHARMA, D.N., RATH, G.K. and JULKA, P.K., 2009. Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma. Journal of cancer research and therapeutics, 5(2), pp. 78-84.

BEN-SHLOMO, Y., EVANS, S., PATEL, B., ANSON, K., MUIR, G., PERSAD, R., METCALFE, C., CHINEGWUNDOH, F. and PROCESS STUDY GROUP, 2009. Differences in the epidemiology and presentation of prostate cancer in Black and White men in England: lessons learnt from the process study. BJU international, 103(6), pp. 723-724.

CHEN, L., DAVEY SMITH, G., EVANS, D.M., COX, A., LAWLOR, D.A., DONOVAN, J., YUAN, W., DAY, I.N., MARTIN, R.M., LANE, A., RODRIGUEZ, S., DAVIS, M., ZUCCOLO, L., COLLIN, S.M., HAMDY, F., NEAL, D. and LEWIS, S.J., 2009. Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 18(11), pp. 2874-2881.

COLLIN, S.M., METCALFE, C., DONOVAN, J.L., ATHENE LANE, J., DAVIS, M., NEAL, D.E., HAMDY, F.C. and MARTIN, R.M., 2009. Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study. European journal of cancer (Oxford, England : 1990), 45(18), pp. 3254-3261.

COLLIN, S.M., METCALFE, C., ZUCCOLO, L., LEWIS, S.J., CHEN, L., COX, A., DAVIS, M., LANE, J.A., DONOVAN, J., SMITH, G.D., NEAL, D.E., HAMDY, F.C., GUDMUNDSSON, J., SULEM, P., RAFNAR, T., BENEDIKTSDOTTIR, K.R., EELES, R.A., GUY, M., KOTE-JARAI, Z., UK GENETIC PROSTATE CANCER STUDY GROUP, MORRISON, J., AL OLAMA, A.A., STEFANSSON, K., EASTON, D.F. and MARTIN, R.M., 2009. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 18(9), pp. 2528-2539.

GILBERT, R., METCALFE, C., OLIVER, S.E., WHITEMAN, D.C., BAIN, C., NESS, A., DONOVAN, J., HAMDY, F., NEAL, D.E., LANE, J.A. and MARTIN, R.M., 2009. Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis. International journal of cancer.Journal international du cancer, 125(6), pp. 1414-1423.

MARTIN, R.M., VATTEN, L., GUNNELL, D., ROMUNDSTAD, P. and NILSEN, T.I., 2009. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway. Cancer causes & control : CCC, 20(7), pp. 1181-1192.

MEVCHA, A., CALLEARY, J. and GILLATT, D.A., 2009. Re: Ocular side-effects of urological pharmacy. BJU international, 103(2), pp. 271-272.

MEVCHA, A. and GILLATT, D., 2009. Suspicious testicular lumps warrant urgent referral. The Practitioner, 253(1715), pp. 23-4, 26.

MEVCHA, A., GULUR, D.M., PERSAD, R. and GILLATT, D., 2009. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU international, 103(10), pp. 1440; author reply 1440-1.

MEYER, J.P., BLICK, C., ARUMAINAYAGAM, N., HURLEY, K., GILLATT, D., PERSAD, R. and FAWCETT, D., 2009. A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: revisiting the initial experience, and results in 104 patients. BJU international, 103(5), pp. 680-683.

MOORE, A.L., DIMITROPOULOU, P., LANE, A., POWELL, P.H., GREENBERG, D.C., BROWN, C.H., DONOVAN, J.L., HAMDY, F.C., MARTIN, R.M. and NEAL, D.E., 2009. Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer. BJU international, 104(11), pp. 1592-1598.

NEAL, D.E., DONOVAN, J.L., MARTIN, R.M. and HAMDY, F.C., 2009. Screening for prostate cancer remains controversial. Lancet, 374(9700), pp. 1482-1483.

OXLEY, J.D., COTTRELL, A.M., ADAMS, S. and GILLATT, D., 2009. Ketamine cystitis as a mimic of carcinoma in situ. Histopathology, 55(6), pp. 705-708.

PASHAYAN, N., PHAROAH, P., NEAL, D.E., HAMDY, F., DONOVAN, J., MARTIN, R.M., GREENBERG, D. and DUFFY, S.W., 2009. Stage shift in PSA-detected prostate cancers - effect modification by Gleason score. Journal of medical screening, 16(2), pp. 98-101.

ROWLANDS, M.A., GUNNELL, D., HARRIS, R., VATTEN, L.J., HOLLY, J.M. and MARTIN, R.M., 2009. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. International journal of cancer.Journal international du cancer, 124(10), pp. 2416-2429.

SHARMA, D.N., BAHL, A., THULKAR, S., RATH, G.K., BASU, K.S., BANSAL, A. and JULKA, P.K., 2009. Radiation dose escalation by percutaneous interstitial brachytherapy in locally advanced non-small cell lung cancer. The Indian journal of chest diseases & allied sciences, 51(2), pp. 103-106.

SHUKLA, N., HOTSTON, M., PERSAD, R., ANGELINI, G.D. and JEREMY, J.Y., 2009. The administration of folic acid improves erectile function and reduces intracavernosal oxidative stress in the diabetic rabbit. BJU international, 103(1), pp. 98-103.

SHUKLA, N., ROSSONI, G., HOTSTON, M., SPARATORE, A., DEL SOLDATO, P., TAZZARI, V., PERSAD, R., ANGELINI, G.D. and JEREMY, J.Y., 2009. Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU international, 103(11), pp. 1522-1529.

THOMAS, F., PATEL, S., HOLLY, J.M., PERSAD, R., BAHL, A. and PERKS, C.M., 2009. Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor. The Prostate, 69(2), pp. 219-224.

UZOH, C.C., PERKS, C.M., BAHL, A., HOLLY, J.M., SUGIONO, M. and PERSAD, R.A., 2009. PTEN-mediated pathways and their association with treatment-resistant prostate cancer. BJU international, 104(4), pp. 556-561.

VOJTECHOVA, P. and MARTIN, R.M., 2009. The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis. Cancer causes & control : CCC, 20(7), pp. 1091-1105.

2008

ARUMAINAYAGAM, N., MCGRATH, J., JEFFERSON, K.P. and GILLATT, D.A., 2008. Introduction of an enhanced recovery protocol for radical cystectomy. BJU international, 101(6), pp. 698-701.

AYRES, B.E., GILLATT, D., MCPHAIL, S., COTTRELL, A., MCGRATH, J., COTTIER, B., VERNE, J., PERSAD, R.A. and AUS SECTION OF ONCOLOGY AND SOUTH WEST PUBLIC HEALTH OBSERVATORY, 2008. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU international, 102(8), pp. 1045.

BAHL, A., SHARMA, D.N., BASU, J., RATH, G.K. and JULKA, P.K., 2008. Pre-treatment anemia evaluation in cancer patients attending radiotherapy clinic: results from a single Indian center. Indian journal of medical sciences, 62(10), pp. 417-420.

BEN-SHLOMO, Y., EVANS, S., IBRAHIM, F., PATEL, B., ANSON, K., CHINEGWUNDOH, F., CORBISHLEY, C., DORLING, D., THOMAS, B., GILLATT, D., KIRBY, R., MUIR, G., NARGUND, V., POPERT, R., METCALFE, C., PERSAD, R. and PROCESS STUDY GROUP, 2008. The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. European urology, 53(1), pp. 99-105.

BURDEN, H.P., DAVIS, C.R., TATE, S., PERSAD, R., HOLMES, C.H. and WHITTINGTON, K., 2008. The trends in prostate specific antigen usage amongst United Kingdom urologists--a questionnaire based study. BMC urology, 8, pp. 17.

BURDEN, H.P., RANASINGHE, W. and PERSAD, R., 2008. Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practising evidence-based medicine? BJU international, 101(10), pp. 1202-1204.

COLLIN, S.M., MARTIN, R.M., METCALFE, C., GUNNELL, D., ALBERTSEN, P.C., NEAL, D., HAMDY, F., STEPHENS, P., LANE, J.A., MOORE, R. and DONOVAN, J., 2008. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. The lancet oncology, 9(5), pp. 445-452.

COLLIN, S.M., METCALFE, C., DONOVAN, J., LANE, J.A., DAVIS, M., NEAL, D., HAMDY, F. and MARTIN, R.M., 2008. Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study. BJU international, 102(10), pp. 1400-1406.

COTTRELL, A., WARREN, K., AYRES, R., WEINSTOCK, P., KUMAR, V. and GILLATT, D., 2008. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU international, 102(9), pp. 1178-9; author reply 1179.

COTTRELL, A.M. and GILLATT, D., 2008. Consider ketamine misuse in patients with urinary symptoms. The Practitioner, 252(1711), pp. 5.

COTTRELL, A.M. and GILLATT, D., 2008. Early detection of erectile dysfunction may prevent CVD. The Practitioner, 252(1702), pp. 21-2, 25-6.

EVANS, S., METCALFE, C., IBRAHIM, F., PERSAD, R. and BEN-SHLOMO, Y., 2008. Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. International journal of cancer.Journal international du cancer, 123(2), pp. 430-435.

HOLLY, J.M., 2008. Endocrine and metabolic determinants of cancer risk. Preface. Best practice & research.Clinical endocrinology & metabolism, 22(4), pp. vii-viii.

HOLLY, J.M. and PERKS, C.M., 2008. Cancer as an endocrine problem. Best practice & research.Clinical endocrinology & metabolism, 22(4), pp. 539-550.

HOTSTON, M., JEREMY, J.Y., BLOOR, J., GREAVES, N.S., PERSAD, R., ANGELINI, G. and SHUKLA, N., 2008. Homocysteine and copper interact to promote type 5 phosphodiesterase expression in rabbit cavernosal smooth muscle cells. Asian Journal of Andrology, 10(6), pp. 905-913.

HUSSAIN, S., GUNNELL, D., DONOVAN, J., MCPHAIL, S., HAMDY, F., NEAL, D., ALBERTSEN, P., VERNE, J., STEPHENS, P., TROTTER, C. and MARTIN, R.M., 2008. Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004. BJU international, 101(5), pp. 547-555.

JOTHYBASU, K.S., BAHL, A., SUBRAMANI, V., SHARMA, D.N. and RATH, G.K., 2008. Does image-guided radiotherapy (IG-IMRT) improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT: In regard to Chung et al. (Int J Radiat Oncol Biol Phys 2008. In press). International journal of radiation oncology, biology, physics, 72(4), pp. 1273; author reply 1273.

KUMAR, M., BAHL, A., SHARMA, D.N., AGARWAL, S., HALANAIK, D., KUMAR, R. and RATH, G.K., 2008. Sarcomatoid squamous cell carcinoma of uterine cervix: pathology, imaging, and treatment. Journal of cancer research and therapeutics, 4(1), pp. 39-41.

MALDE, R., MOSS, T., MALCOLM, G., WHITTLESTONE, T. and BAHL, A., 2008. Multiple intraosseous calvarial hemangiomas mimicking metastasis from renal cell carcinoma. Advances in urology, , pp. 176392.

MARTIN, R.M., VATTEN, L., GUNNELL, D., ROMUNDSTAD, P. and NILSEN, T.I., 2008. Lower urinary tract symptoms and risk of prostate cancer: the HUNT 2 Cohort, Norway. International journal of cancer.Journal international du cancer, 123(8), pp. 1924-1928.

METCALFE, C., EVANS, S., IBRAHIM, F., PATEL, B., ANSON, K., CHINEGWUNDOH, F., CORBISHLEY, C., GILLATT, D., KIRBY, R., MUIR, G., NARGUND, V., POPERT, R., PERSAD, R., BEN-SHLOMO, Y. and PROCESS STUDY GROUP, 2008. Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort study. British journal of cancer, 99(7), pp. 1040-1045.

METCALFE, C., PATEL, B., EVANS, S., IBRAHIM, F., ANSON, K., CHINEGWUNDOH, F., CORBISHLEY, C., DORLING, D., THOMAS, B., GILLATT, D., KIRBY, R., MUIR, G., NARGUND, V., POPERT, R., PERSAD, R., BEN-SHLOMO, Y. and PROCESS STUDY GROUP, 2008. The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study. BJU international, 102(10), pp. 1407-1412.

MORRISON, A.A., VINEY, R.L., SALEEM, M.A. and LADOMERY, M.R., 2008. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. American journal of physiology.Renal physiology, 295(1), pp. F12-7.

RATH, G.K., JULKA, P.K., THULKAR, S., SHARMA, D.N., BAHL, A. and BHATNAGAR, S., 2008. Radiofrequency ablation of hepatic metastasis: results of treatment in forty patients. Journal of cancer research and therapeutics, 4(1), pp. 14-17.

RENNEL, E., WAINE, E., GUAN, H., SCHULER, Y., LEENDERS, W., WOOLARD, J., SUGIONO, M., GILLATT, D., KLEINERMAN, E., BATES, D. and HARPER, S., 2008. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. British journal of cancer, 98(7), pp. 1250-1257.

RODDAM, A.W., ALLEN, N.E., APPLEBY, P., KEY, T.J., FERRUCCI, L., CARTER, H.B., METTER, E.J., CHEN, C., WEISS, N.S., FITZPATRICK, A., HSING, A.W., LACEY, J.V.,JR, HELZLSOUER, K., RINALDI, S., RIBOLI, E., KAAKS, R., JANSSEN, J.A., WILDHAGEN, M.F., SCHRODER, F.H., PLATZ, E.A., POLLAK, M., GIOVANNUCCI, E., SCHAEFER, C., QUESENBERRY, C.P.,JR, VOGELMAN, J.H., SEVERI, G., ENGLISH, D.R., GILES, G.G., STATTIN, P., HALLMANS, G., JOHANSSON, M., CHAN, J.M., GANN, P., OLIVER, S.E., HOLLY, J.M., DONOVAN, J., MEYER, F., BAIRATI, I. and GALAN, P., 2008. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Annals of Internal Medicine, 149(7), pp. 461-71, W83-8.

ROSENDAHL, A.H., HOLLY, J.M., CELANDER, M. and FORSBERG, G., 2008. Systemic IGF-I administration stimulates the in vivo growth of early, but not advanced, renal cell carcinoma. International journal of cancer.Journal international du cancer, 123(6), pp. 1286-1291.

ZUCCOLO, L., HARRIS, R., GUNNELL, D., OLIVER, S., LANE, J.A., DAVIS, M., DONOVAN, J., NEAL, D., HAMDY, F., BEYNON, R., SAVOVIC, J. and MARTIN, R.M., 2008. Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 17(9), pp. 2325-2336.

2007

ARUMAINAYAGAM, N. and GILLATT, D., 2007. Acute scrotal pain needs prompt investigation. The Practitioner, 251(1690), pp. 24, 26, 28-9.

AYRES, B.E., THOMAS, F., ZACHAROWSKI, K., LIGHTMAN, S.L. and PERSAD, R.A., 2007. The stress response in laparoscopic urological surgery. BJU international, 99(6), pp. 1331-1332.

BERESFORD, M., LYBURN, I., SANGHERA, B., MAKRIS, A. and WONG, W.L., 2007. Serial integrated (18)F-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma. The breast journal, 13(4), pp. 424-425.

BROOKS, M.E., OKEKE, A., COLLINS, J., PERSAD, R. and WRIGHT, M., 2007. Retroperitoneoscopic nephrectomy for pelvic kidney. Surgical laparoscopy, endoscopy & percutaneous techniques, 17(5), pp. 469-471.

HOTSTON, M.R., JEREMY, J.Y., BLOOR, J., KOUPPARIS, A., PERSAD, R. and SHUKLA, N., 2007. Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide. BJU international, 99(3), pp. 612-618.

JEFFERSON, K.P. and GILLATT, D.A., 2007. Hereditary urological cancer syndromes. Nature clinical practice.Urology, 4(4), pp. 218-226.

JUDGE, A., EVANS, S., GUNNELL, D.J., ALBERTSEN, P.C., VERNE, J. and MARTIN, R.M., 2007. Patient outcomes and length of hospital stay after radical prostatectomy for prostate cancer: analysis of hospital episodes statistics for England. BJU international, 100(5), pp. 1040-1049.

LADOMERY, M.R., HARPER, S.J. and BATES, D.O., 2007. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm. Cancer letters, 249(2), pp. 133-142.

MARTIN, R.M., 2007. Commentary: prostate cancer is omnipresent, but should we screen for it? International journal of epidemiology, 36(2), pp. 278-281.

OXLEY, J.D., SULLIVAN, J., MITCHELMORE, A. and GILLATT, D.A., 2007. Metastatic renal oncocytoma. Journal of clinical pathology, 60(6), pp. 720-722.

PAYNE, H.A. and GILLATT, D.A., 2007. Differences and commonalities in the management of locally advanced prostate cancer: results from a survey of oncologists and urologists in the UK. BJU international, 99(3), pp. 545-553.

2006

BAHL, A., SHARMA, D.N., JULKA, P.K., DAS, A. and RATH, G.K., 2006. Sweat gland carcinoma with lung metastases. Journal of cancer research and therapeutics, 2(4), pp. 209-211.

BARRASS, B.J., THURAIRAJA, R., COLLINS, J.W., GILLATT, D. and PERSAD, R.A., 2006. Optimal nutrition should improve the outcome and costs of radical cystectomy. Urologia internationalis, 77(2), pp. 139-142.

BOR, Y.C., SWARTZ, J., MORRISON, A., REKOSH, D., LADOMERY, M. and HAMMARSKJOLD, M.L., 2006. The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron. Genes & development, 20(12), pp. 1597-1608.

CHURCH, D.N. and BAHL, A., 2006. Clinical review - small cell carcinoma of the bladder. Cancer treatment reviews, 32(8), pp. 588-593.

GILLATT, D., 2006. Antiandrogen treatments in locally advanced prostate cancer: are they all the same? Journal of cancer research and clinical oncology, 132 Suppl 1, pp. S17-26.

HOLLY, J. and PERKS, C., 2006. Growth hormone and cancer: are we asking the right questions?*. Clinical endocrinology, 64(2), pp. 122-124.

HOLLY, J. and PERKS, C., 2006. The role of insulin-like growth factor binding proteins. Neuroendocrinology, 83(3-4), pp. 154-160.

HOLLY, J., SABIN, M., PERKS, C. and SHIELD, J., 2006. Adipogenesis and IGF-1. Metabolic syndrome and related disorders, 4(1), pp. 43-50.

HOTSTON, M., SHUKLA, N., BLOOR, J., PERSAD, R. and JEREMY, J.Y., 2006. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJU international, 98(6), pp. 1331-1332.

JEREMY, J.Y., JONES, R.A., KOUPPARIS, A.J., HOTSTON, M., ANGELINI, G.D., PERSAD, R. and SHUKLA, N., 2006. Re: Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. The Journal of urology, 175(3 Pt 1), pp. 1175-1176.

KOUPPARIS, A.J., JEREMY, J., ANGELINI, G., PERSAD, R. and SHUKLA, N., 2006. Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation in the corpus cavernosum in the rabbit. BJU international, 98(2), pp. 440-444.

SHUKLA, N., KOUPPARIS, A., JONES, R.A., ANGELINI, G.D., PERSAD, R. and JEREMY, J.Y., 2006. Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit. European journal of pharmacology, 531(1-3), pp. 201-208.

THURAIRAJA, R., OSBORN, J., MCFARLANE, J., BAHL, A. and PERSAD, R., 2006. Radical prostatectomy with positive surgical margins: how are patients managed? BJU international, 97(3), pp. 445-450.

Back to top

Page updated: 27 September, 2012